ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
Heidelberg University at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Heidelberg University takes part in 6 sessions at ESMO 2026 in Madrid. Its work spans ovarian and endometrial cancers, immune approaches and rare tumours. Topics include olaparib alone or with durvalumab before ovarian cancer surgery, and how dose reductions relate to nirogacestat safety and effectiveness in desmoid tumours.
| Organization | ESMO 2026 Attendance |
|---|---|
Heidelberg University Heidelberg, Germany | |
Public research university in Heidelberg, Germany, with medical faculties in Heidelberg and Mannheim. | Satellite Fri Oct 23 10:25–10:50 New ADC Horizons: Sequencing Strategies, Emerging Therapies, and the Next Frontier in Gynaecological cancers Poster Fri Oct 23 13:00–15:00 Anti-tumour and anti-angiogenic activity of the pan-ID protein inhibitor X6632 Breast cancerMelanoma & skin cancers Talk Fri Oct 23 14:10–14:30 Current evidence and development of ADCs in EC Gynaecological cancers Talk Fri Oct 23 16:15–16:35 Presentation by Expert Sarcoma, CNS, head & neck and rare cancers Poster Mon Oct 26 12:00–12:45 Poster Mon Oct 26 12:00–12:45 Effect of dose reduction on the safety and efficacy of nirogacestat in patients with desmoid tumors: Post hoc analyses of the DeFi trial Sarcoma, CNS, head & neck and rare cancers |
Find decision makers at Heidelberg University
Tell us what you sell and we’ll find the people at Heidelberg University most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction